LMWF-5A resulted in a significant decrease in pain at 12 weeks compared to vehicle control ( -0.93 vs -0.72 ; estimated difference from control : -0.25 , p = 0.004 ) ; an injection volume effect was not observed ( p = 0.64 ) .